Item 5. OTHER INFORMATION

Trading Plans or Rule 10b5-1 Trading Plans

The table below summarizes the material terms of trading arrangements adopted by any of our executive officers or directors during the March 2026 quarter. All of the trading arrangements listed below are intended to satisfy the affirmative defense of Rule 10b5-1(c).


Name	Title	Date of Adoption	End Date¹	Aggregate number of ordinary shares to be sold pursuant to the trading agreement
James C. Lee	Executive Vice President, Chief Legal Officer and Corporate Secretary	January 29, 2026	January 29, 2027	19,958
Dr. John C. Morris	Executive Vice President and Chief Technology Officer	January 29, 2026	May 7, 2027	81,462
Ban Seng Teh	Executive Vice President, Global Sales and Sales Operations	February 11, 2026	February 11, 2027	54,366
Dr. William D. Mosley	Board Chair and Chief Executive Officer	February 18, 2026	April 30, 2027	360,000
Prat S. Bhatt	Director	March 3, 2026	May 31, 2027	2,580

¹ The plan will expire on the earlier of the end date or the completion of all transactions under the trading arrangement.

Previous: Item 1A. RISK FACTORS · Next: Item 6. EXHIBITS